Alphamab Oncology — Share Issue/Capital Change 2019

Dec 1, 2019

Please use this form if you want the Hong Kong Offer Shares to be issued in your name 如 閣下欲以本身名義登記將獲發行的香港發售股份，請使用本表格

This Application Form uses the same terms as defined in the prospectus of Alphamab Oncology (the “ Company ”) dated December 2, 2019 (the “ Prospectus ”). Staple your 本申請表格使用康寧傑瑞生物製藥（「 本公司 」）於2019年12月2日刊發的招股章程（「 招股章程 」）所界定的相同詞彙。 payment Neither this Application Form nor the Prospectus constitutes an offer to sell or the solicitation of an offer to buy any Hong Kong Offer Shares in any jurisdiction other than Hong Kong. The Hong Kong Offer Shares may not be offered or sold in the here United States without registration or an exemption from registration under the U.S. Securities Act. 請將股款 本申請表格及招股章程概不構成在香港以外任何司法管轄區出售或要約購買任何香港發售股份的要約或游說。若無根 據美國《證券法》登記或獲豁免登記，香港發售股份不得在美國提呈發售或出售。 緊釘在此 This Application Form and the Prospectus may not be forwarded or distributed or reproduced (in whole or in part) in any manner whatsoever in any jurisdiction where such forwarding, distribution or reproduction is not permitted under the law of that jurisdiction. 在任何根據當地法例不得發送、派發或複製本申請表格及招股章程的司法管轄區內概不得發送或派發或複製（不論方 式，也不論全部或部分）本申請表格及招股章程。

Copies of the Prospectus, all related Application Forms and the other documents specified in the “Documents Delivered to the Registrar of Companies and Available for Inspection” section in Appendix VI to the Prospectus, have been registered by the Registrar of Companies in Hong Kong as required by section 342C of the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Chapter 32 of the Laws of Hong Kong). Hong Kong Exchanges and Clearing Limited, The Stock Exchange of Hong Kong Limited (the “ Stock Exchange ”), Hong Kong Securities Clearing Company Limited (“ HKSCC ”), the Securities and Futures Commission of Hong Kong (the “ SFC ”) and the Registrar of Companies in Hong Kong take no responsibility for the contents of these documents.

招股章程、所有相關申請表格及招股章程附錄六「送呈公司註冊處處長及備查文件」一節所述其他文件已按香港法例第 32章《公司（清盤及雜項條文）條例》第342C條規定送呈香港公司註冊處處長登記。香港交易及結算所有限公司、香港 聯合交易所有限公司（「 聯交所 」）、香港中央結算有限公司（「 香港結算 」）、香港證券及期貨事務監察委員會（「 證監會 」） 及香港公司註冊處處長對此等文件的內容概不負責。 ALPHAMAB ONCOLOGY 康寧傑瑞生物製藥 (Incorporated in the Cayman Islands with limited liability) （於開曼群島註冊成立的有限公司） Stock Code : 9966 股份代號 : 9966 Maximum Offer Price : HK$10.20 per Share, plus brokerage of 1.0%, SFC transaction levy of 0.0027% and Stock Exchange trading fee of 0.005% (payable in full on application in Hong Kong Dollars and subject to refund) 最高發售價 : 每股股份10.20港元，另加1.0%經紀佣金、0.0027% 證監會交易徵費及0.005%聯交所交易費（須於申請 時以港元繳足，多繳款項可予退還） You should read this Application Form in conjunction with the Prospectus, which contains further information on the application procedures. ， 一 。 招股章程尚有其他關於申請程序的資料 本申請表格應與招股章程 併閱讀 Application Form 申請表格 To: Alphamab Oncology 致： 康寧傑瑞生物製藥 Joint Sponsors 聯席保薦人 Joint Global Coordinators 聯席全球協調人 Joint Bookrunners 聯席賬簿管理人 Joint Lead Managers 聯席牽頭經辦人 Hong Kong Underwriters 香港包銷商

Applicants’ declaration

I/We agree to the terms and conditions and application procedures in this Application Form and the Prospectus. Please refer to the “Effect of completing and submitting this Application Form” section of this Application Form.

申請人聲明 本人╱吾等同意本申請表格及招股章程的條款及條件以 及申請程序。請參閱本申請表格「填寫及遞交本申請表格 的效用」一節。

Warning: Only one application may be made for the benefit of any person. Please refer to the last four bullets of “Effect of completing and submitting this Application Form” section.

警告： 任何人士只限作出一次為其利益而進行的認購申 。 請 請參閱「填寫及遞交本申請表格的效用」一節最後四 點。

Please use this form if you want the Hong Kong Offer Shares to be issued in your name 如 閣下欲以本身名義登記將獲發行的香港發售股份，請使用本表格

Signed by (all) applicant(s) (all joint applicants must sign): 由（所有）申請人簽署（所有聯名申請人必須簽署）：

For Broker use 此欄供經紀填寫 Lodged by 遞交申請的經紀 Broker No. 經紀號碼 Broker’s Chop 經紀印章

Date 日期： /

/

D日 M月 Y年 Number of Hong Kong Offer Shares applied for (not more than Cheque/banker’s cashier order number 支票╱銀行本票號碼 8,971,000 shares) 申請香港發售股份數目（不超過8,971,000股股份） Name of bank on which cheque/banker’s cashier order is drawn (see “How to make your application” section) 兌現支票╱銀行本 Total amount 總額 票的銀行名稱（見「申請手續」一節） HK$ 港元 Name in English (in BLOCK letters) 英文姓名╱名稱（ 正楷 ） Family name or company name 姓氏或公司名稱 Forename(s) 名字 Name in Chinese 中文姓名╱名稱 Family name or company name 姓氏或公司名稱 Forename(s) 名字 Occupation in English 職業（以英文填寫） Hong Kong Identity Card No./Passport No./Hong Kong Business Registration No. (Please delete as appropriate) 香港身份證號碼╱ 護照號碼╱香港商業登記號碼[] （請刪去不適用者） Names of all other joint applicants in English (if any, in BLOCK Hong Kong Identity Card No./Passport No./Hong Kong Business Registration No. of all other joint applicants (Please delete as appropriate) 所有其他聯名申請人 letters) 所有其他聯名申請人的英文姓名╱名稱（如有， 正楷 ） 的香港身份證號碼╱護照號碼╱香港商業登記號碼[] （請刪去不適用者） 1) 1) 2) 2) 3) 3) Hong Kong address in English and telephone no. (joint applicants should give the address and the telephone number of first-named applicant only, in BLOCK letters)y, in BLOCK letters), in BLOCK letters)) 香港地址（以英文 正楷 填寫）及電話號碼（聯名申請人只須填寫排名首位申請人的地址及電話號碼） Telephone No. 電話號碼 For Nominees: You will be treated as applying for your own benefit if you do not complete this section. Please provide an account number or identification code for each (joint) beneficial owner. 由代名人遞交：代名人若不填寫本節，是項 申請將視作為 閣下利益提出。請填寫每名（聯名）實益擁 有人的賬戶號碼或識別編碼。

Hong Kong address in English and telephone no. (joint applicants should give the address and the telephone number of first-named applicant only, in BLOCK letters)y, in BLOCK letters), in BLOCK letters)) 香港地址（以英文 正楷 填寫）及電話號碼（聯名申請人只須填寫排名首位申請人的地址及電話號碼）

ADDRESS LABEL 地址標貼 (Your name(s) and address in Hong Kong in BLOCK letters 請以 正楷 填寫 閣下 姓名╱名稱 及香港 地址 )

For internal use 此欄供內部使用

Please use this form if you want the Hong Kong Offer Shares to be issued in your name 如 閣下欲以本身名義登記將獲發行的香港發售股份，請使用本表格

• (1) An individual must provide his Hong Kong Identity Card number or, if he does not hold a Hong Kong Identity Card, his passport number. A body corporate must provide its Hong Kong Business Registration number. Each joint applicant must provide its or his relevant number. The Hong Kong Identity Card number(s)/passport number(s)/Hong Kong Business Registration number(s) will be transferred to a third party for checking the Application Form’s validity.

• 個別人士必須填寫其香港身份證號碼或（如非香港身份證持有人）護照號碼。法人團體必須填寫其 香港商業登記號碼。每名聯名申請人均必須提供其相關號碼。該等香港身份證號碼╱護照號碼╱ 香港商業登記號碼將轉交第三方以核實申請表格的有效性。

• (2) Part of the Hong Kong Identity Card number/passport number of you or, for joint applicants, the firstnamed applicant may be printed on your refund cheque (if any). Your banker may require verification of your Hong Kong Identity Card number/passport number before you can cash your refund cheque. 退款支票（如有）上或會印有 閣下或（如屬聯名申請人）排名首位申請人的香港身份證號碼╱護 照號碼一部分。銀行兌現退款支票前或會要求查證 閣下的香港身份證號碼╱護照號碼。

• (3) If an application is made by an unlisted company and: • the principal business of that company is dealing in securities; and • you exercise statutory control over that company, then the application will be treated as being made for your benefit. 如申請人是一家非上市公司，而： • 該公司主要從事證券買賣業務；及 • 閣下對該公司可行使法定控制權， 是項申請將視作為 閣下的利益提出。

This page is intentionally left blank 此乃白頁 特意留空

Please use this form if you want the Hong Kong Offer Shares to be issued in your name

How to make your application

1. Use the table below to calculate how much you must pay. Your application must be for a minimum of 1,000 Hong Kong Offer Shares and in one of the numbers set out in the table, or your application will be rejected.

			ALPHAMAB ONCOLOGY
			(Stock Code: 9966)
			(HK$10.20 per Hong Kong Offer Share)
			NUMBER OF HONG KONG OFFER SHARES THAT MAY BE APPLIED FOR AND PAYMENTS
			No. of Amount No. of Amount No. of Amount No. of Amount
		Hong Kong payable Hong Kong payable Hong Kong payable Hong Kong payable
		Offer Shares on application Offer Shares on application Offer Shares on application Offer Shares on application
		applied for HK$ applied for HK$ applied for HK$ applied for HK$
(1) 2. 3.		1,000 2,000 3,000 4,000 5,000 6,000 7,000 8,000 9,000 10,000 15,000 10,302.79 20,605.57 30,908.36 41,211.14 51,513.93 61,816.71 72,119.50 82,422.28 92,725.07 103,027.85 154,541.78 20,000 25,000 30,000 35,000 40,000 45,000 50,000 60,000 70,000 80,000 90,000 206,055.71 257,569.64 309,083.56 360,597.49 412,111.42 463,625.34 515,139.27 618,167.12 721,194.98 824,222.83 927,250.69 100,000 200,000 300,000 400,000 500,000 600,000 700,000 800,000 900,000 1,000,000 2,000,000 1,030,278.54 2,060,557.08 3,090,835.62 4,121,114.16 5,151,392.70 6,181,671.24 7,211,949.78 8,242,228.32 9,272,506.86 10,302,785.40 20,605,570.80 3,000,000 4,000,000 5,000,000 6,000,000 7,000,000 8,000,000 8,971,000(1) 30,908,356.20 41,211,141.60 51,513,927.00 61,816,712.40 72,119,497.80 82,422,283.20 92,426,287.82 Maximum number of Hong Kong Offer Shares you may apply for. Complete the form in English in BLOCK letters and sign it. Only written signatures will be accepted (and not by way of personal chop). Staple your cheque or banker’s cashier order to the form. Each application for the Hong Kong Offer Shares must be accompanied by either one separate cheque or one separate banker’s cashier order. Your application will be rejected if your cheque or banker’s cashier order does not meet all the following requirements: The cheque must: Banker’s cashier order must: Sample 樣版
		•	be in Hong Kong dollars;
		•	not be post-dated;
		•	be made payable to “HORSFORD NOMINEES LIMITED–Alphamab Oncology PUBLIC
			OFFER”;
		•	be crossed “Account Payee Only”;
		•	be drawn on your Hong Kong dollar bank • be issued by a licensed bank in Hong
			account in Hong Kong; and Kong, and have your name certified on the
		•	show your account name, which must back by a person authorised by the bank.
			either be pre-printed on the cheque, or The name on the banker’s cashier order
			be endorsed on the back by a person must correspond with your name. If it is
			authorised by the bank. This account name a joint application, the name on the back
			must correspond with your name. If it is a of the banker’s cashier order must be the
			joint application, the account name must same as the first-named applicant’s name.
			be the same as the first-named applicant’s
			name.

Please use this form if you want the Hong Kong Offer Shares to be issued in your name

1. Tear off the Application Form, fold it once and lodge your completed Application Form (with cheque or banker’s cashier order attached) to one of the collection boxes at any of the following branches of the receiving bank, Standard Chartered Bank (Hong Kong) Limited:

Region

Branch Name

Address

Hong Kong Island Des Voeux Road Branch Standard Chartered Bank Building, 4-4A, Des Voeux Road Central, Central

Aberdeen Branch Shop 4A, G/F and Shop 1, 1/F, Aberdeen Centre Site 5, No.6-12 Nam Ning Street, Aberdeen Kowloon Telford Gardens Branch Shop P9-12, Telford Centre, Telford Gardens, Tai Yip Street, Kowloon Bay Lok Fu Shopping Centre Shop G201, G/F., Lok Fu Shopping Centre Branch New Territories Maritime Square Branch Shop 308E, Level 3, Maritime Square, Tsing Yi 5. Your Application Form can be lodged at these times: — Monday, December 2, 2019 9:00 a.m. to 5:00 p.m. — Tuesday, December 3, 2019 9:00 a.m. to 5:00 p.m. — Wednesday, December 4, 2019 9:00 a.m. to 5:00 p.m. Thursday, December 5, 2019 — 9:00 a.m. to 12:00 noon 6. The latest time for lodging your application is 12:00 noon on Thursday, December 5, 2019. The application lists will be open between 11:45 a.m. to 12:00 noon on that day, subject only to the weather conditions, as described in “10. Effect of Bad Weather on the Opening of the Application Lists” in the “How to Apply for Hong Kong Offer Shares” section of the Prospectus.

如 閣下欲以本身名義登記將獲發行的香港發售股份，請使用本表格

申請手續

1. 請使用下表計算 閣下應付的款項。 閣下申請認購的股數須至少為1,000股香港發售股份，並為 下表所列的其中一個數目，否則恕不受理。

康寧傑瑞生物製藥 （股份代號：9966） （每股香港發售股份10.20港元） 可供申請認購香港發售股份數目及應繳款項

申請手續 1. 請使用下表計算 閣下應付的款項。 閣下申請認購的股數須至少為1,000股香港發售股份，並為 下表所列的其中一個數目，否則恕不受理。	申請手續 1. 請使用下表計算 閣下應付的款項。 閣下申請認購的股數須至少為1,000股香港發售股份，並為 下表所列的其中一個數目，否則恕不受理。	申請手續 1. 請使用下表計算 閣下應付的款項。 閣下申請認購的股數須至少為1,000股香港發售股份，並為 下表所列的其中一個數目，否則恕不受理。	申請手續 1. 請使用下表計算 閣下應付的款項。 閣下申請認購的股數須至少為1,000股香港發售股份，並為 下表所列的其中一個數目，否則恕不受理。
康寧傑瑞生物製藥 （股份代號：9966） （每股香港發售股份10.20港元） 可供申請認購香港發售股份數目及應繳款項
申請認購的 香港發售 股份數目 申請時 應繳款項 港元	申請認購的 香港發售 股份數目 申請時 應繳款項 港元	申請認購的 香港發售 股份數目 申請時 應繳款項 港元	申請認購的 香港發售 股份數目 申請時 應繳款項 港元
1,000 2,000 3,000 4,000 5,000 6,000 7,000 8,000 9,000 10,000 15,000 10,302.79 20,605.57 30,908.36 41,211.14 51,513.93 61,816.71 72,119.50 82,422.28 92,725.07 103,027.85 154,541.78	20,000 25,000 30,000 35,000 40,000 45,000 50,000 60,000 70,000 80,000 90,000 206,055.71 257,569.64 309,083.56 360,597.49 412,111.42 463,625.34 515,139.27 618,167.12 721,194.98 824,222.83 927,250.69	100,000 200,000 300,000 400,000 500,000 600,000 700,000 800,000 900,000 1,000,000 2,000,000 1,030,278.54 2,060,557.08 3,090,835.62 4,121,114.16 5,151,392.70 6,181,671.24 7,211,949.78 8,242,228.32 9,272,506.86 10,302,785.40 20,605,570.80 樣版	3,000,000 4,000,000 5,000,000 6,000,000 7,000,000 8,000,000 8,971,000(1) 30,908,356.20 41,211,141.60 51,513,927.00 61,816,712.40 72,119,497.80 82,422,283.20 92,426,287.82
(1) 閣下可申請認購的香港發售股份最高數目。 2. 請以英文正楷填寫及簽署申請表格。僅接納親筆簽名（不得以個人印章代替）。 3. 閣下須將支票或銀行本票釘於表格上。每份香港發售股份申請必須附有一張獨立開出支票或一張 獨立開出銀行本票。 閣下的支票或銀行本票必須符合以下所有規定，否則認購申請將不獲接納： ample
支票必須：		銀行本票必須：
• 為港元； • 不得為期票； • 註明抬頭人為「浩豐代理人有限公司－康寧傑瑞生物製藥公開發售」； • 劃線註明「只准入抬頭人賬戶」；
• 從 閣下在香港的港元銀行賬戶開出； 及 • 顯示 閣下的賬戶名稱，而該賬戶名稱 必須已預印在支票上，或由有關銀行授 權的人士在支票背書。賬戶名稱必須 與 閣下姓名╱名稱相同。如屬聯名申 請，賬戶名稱必須與排名首位申請人的 姓名╱名稱相同。		• 由香港持牌銀行開出，並由有關銀行授 權的人士在銀行本票背面簽署核證 閣 下姓名╱名稱。銀行本票所示姓名╱名 稱須與 閣下姓名╱名稱相同。如屬聯 名申請，銀行本票背面所示姓名╱名稱 必須與排名首位申請人的姓名╱名稱相 同。

如 閣下欲以本身名義登記將獲發行的香港發售股份，請使用本表格

1. 請撕下申請表格，對摺一次，然後將填妥的申請表格（連同隨附的支票或銀行本票）投入收款銀行 渣打銀行（香港）有限公司的下列任何一家分行的收集箱：

地區

分行名稱 地址

港島區 德輔道分行 中環德輔道中4-4A號渣打銀行大廈 香港仔分行 香港仔南寧街6-12號香港仔中心第五期 地下4A舖及一樓1號舖 九龍區 德福花園分行 九龍灣大業街德福花園德福中心商場P9-12號舖 樂富中心分行 樂富中心商場地下G201號舖 新界區 青衣城分行 青衣青衣城3樓308E號舖 5. 閣下可於下列時間遞交申請表格： 2019年12月2日（星期一）— 上午九時正至下午五時正 2019年12月3日（星期二）— 上午九時正至下午五時正 2019年12月4日（星期三）— 上午九時正至下午五時正 2019年12月5日（星期四）— 上午九時正至中午十二時正 6. 截止遞交申請的時間為2019年12月5日（星期四）中午十二時正。本公司將於當日上午十一時四十 五分至中午十二時正期間開始辦理申請登記，唯一會影響此時間的變化因素為當日的天氣情況（詳 見招股章程「如何申請香港發售股份」一節「10. 惡劣天氣對開始辦理申請登記的影響」）。

Please use this form if you want the Hong Kong Offer Shares to be issued in your name

==> picture [172 x 41] intentionally omitted <==

ALPHAMAB ONCOLOGY 康寧傑瑞生物製藥

(Incorporated in the Cayman Islands with limited liability)

GLOBAL OFFERING

Conditions of your application

• confirm that you are aware of the restrictions on the Global Offering in the Prospectus;

A. Who can apply

agree that none of the Company, the Joint Sponsors, the Joint Global Coordinators, the Joint Bookrunners, the Joint Lead Managers, the Underwriters, their respective directors, officers, employees, partners, agents, advisers and any other parties involved in the Global Offering is or will be liable for any information and representations not in the Prospectus (and any supplement to it); undertake and confirm that you or the person(s) for whose benefit

1. You and any person(s) for whose benefit you are applying must be 18 years of age or older and must have a Hong Kong address.

3. If you are a firm, the application must be in the individual members’ names.

4. The number of joint applicants may not exceed 4.

5. If you are a body corporate, the application must be signed by a • undertake and confirm that you or the person(s) for whose benefit duly authorised officer, who must state his or her representative you have made the application have not applied for or taken up, capacity, and stamped with your corporation’s chop. or indicated an interest for, and will not apply for or take up, or 5. You must be outside the United States, not be a United States indicate an interest for, any International Offer Shares under the Person (as defined in Regulation S under the U.S. Securities Act) or International Offering nor participated in the International Offering; a person described in paragraph (h)(3) of Rule 902 of Regulation S • agree to disclose to the Company, our Hong Kong Share under the U.S. Securities Act and not be a legal or natural person of the PRC. Registrar, the receiving bank, the Joint Sponsors, the Joint Global Coordinators, the Joint Bookrunners, the Joint Lead Managers, 6. Unless permitted by the Listing Rules and guidance letters issued the Underwriters and/or their respective advisers and agents any by the Stock Exchange, or any relevant waivers that have been personal data which they may require about you and the person(s) granted by the Stock Exchange, you cannot apply for any Hong for whose benefit you have made the application; Kong Offer Shares if you: • if the laws of any place outside Hong Kong apply to your • are an existing beneficial owner of Shares in the Company application, agree and warrant that you have complied with all such and/or any of its subsidiaries; laws and none of the Company, the Joint Sponsors, the Joint Global • are a director or chief executive officer of the Company and/ Coordinators, the Joint Bookrunners, the Joint Lead Managers and or any of its subsidiaries; the Underwriters nor any of their respective officers or advisers will • are a close associate (as defined in the Listing Rules) of any breach any law outside Hong Kong as a result of the acceptance of the above; of your offer to purchase, or any action arising from your rights • are a core connected person (as defined in the Listing Rules) and obligations under the terms and conditions contained in the of the Company or will become a core connected person of Prospectus and this Application Form; the Company immediately upon completion of the Global • agree that once your application has been accepted, you may not Offering; or rescind it because of an innocent misrepresentation; • have been allocated or have applied for or indicated an • agree that your application will be governed by the laws of Hong interest in any International Offer Shares or otherwise Kong; participate in the International Offering. • represent, warrant and undertake that (i) you understand that the B. If you are a nominee Hong Kong Offer Shares have not been and will not be registered You, as a nominee, may make more than one application for the Hong under the U.S. Securities Act; and (ii) you and any person for Kong Offer Shares by: (i) giving electronic application instructions whose benefit you are applying for the Hong Kong Offer Shares to HKSCC via Central Clearing and Settlement System (“ CCASS ”) (if are outside the United States (as defined in Regulation S) or are a you are a CCASS Participant); or (ii) using a WHITE or YELLOW person described in paragraph (h)(3) of Rule 902 of Regulation S; Application Form, and lodge more than one application in your own name • warrant that the information you have provided is true and accurate; on behalf of different beneficial owners. • agree to accept the Hong Kong Offer Shares applied for, or any C. Effect of completing and submitting this Application Form lesser number allocated to you under the application; By completing and submitting this Application Form, you (and if you are • authorise the Company to place your name(s) on the Company’s joint applicants, each of you jointly and severally) for yourself or as an register of members as the holder(s) of any Hong Kong Offer Shares agent or a nominee on behalf of each person for whom you act: allocated to you, and the Company and/or its agents to send any • undertake to execute all relevant documents and instruct and share certificate(s) and/or any refund cheque(s) to you or the firstauthorise the Company and/or the Joint Global Coordinators (or named applicant for joint application by ordinary post at your own their agents or nominees), as agents of the Company, to execute any risk to the address stated on this application, unless you are eligible documents for you and to do on your behalf all things necessary to to collect the share certificate(s) and/or refund cheque(s) in person; register any Hong Kong Offer Shares allocated to you in your name • declare and represent that this is the only application made and the as required by the Articles of Association;

6. declare and represent that this is the only application made and the only application intended by you to be made to benefit you or the person for whose benefit you are applying;

7. agree to comply with the Companies Ordinance, the Companies (Winding up and Miscellaneous Provisions) Ordinance and the Articles of Association;

8. understand that the Company and the Joint Global Coordinators will rely on your declarations and representations in deciding whether or not to make any allotment of any of the Hong Kong Offer Shares to you and that you may be prosecuted for making a false declaration;

9. confirm that you have read the terms and conditions and application procedures set out in the Prospectus and in this Application Form and agree to be bound by them;

10. confirm that you have received and read the Prospectus and have only relied on the information and representations contained in the Prospectus in making your application and will not rely on any other information or representations except those in any supplement to the Prospectus;

11. (if the application is made for your own benefit) warrant that no other application has been or will be made for your benefit on a WHITE or YELLOW Application Form or by giving electronic application instructions to HKSCC or to the White Form eIPO Service Provider by you or by any one as your agent or by any other person; and

Please use this form if you want the Hong Kong Offer Shares to be issued in your name

If you do not collect your refund cheque(s) and/or share certificate(s) personally within the time period specified for collection, they will be dispatched promptly to the address as specified on this Application Form by ordinary post at your own risk.

• (if you are making the application as an agent for the benefit of another person) warrant that (i) no other application has been or will be made by you as agent for or for the benefit of that person or by that person or by any other person as agent for that person on a WHITE or YELLOW Application Form or by giving electronic application instructions to HKSCC and (ii) you have due authority to sign the Application Form or give electronic application instructions on behalf of that other person as their agent.

If you apply for less than 1,000,000 Hong Kong Offer Shares, your refund cheque(s) and/or share certificate(s) will be sent to the address on the relevant Application Form on or before Wednesday, December 11, 2019, by ordinary post and at your own risk.

D. Power of attorney

Refund of your money

If your application is made through an authorised attorney, the Company and the Joint Global Coordinators may accept or reject your application at their discretion, and on any conditions they think fit, including evidence of the attorney’s authority.

If you do not receive any Hong Kong Offer Shares or if your application is accepted only in part, the Company will refund to you your application monies (including the related 1.0% brokerage, 0.0027% SFC transaction levy and 0.005% Stock Exchange trading fee) without interest. If the Offer Price is less than the maximum Offer Price, the Company will refund to you the surplus application monies (including the related 1.0% brokerage, 0.0027% SFC transaction levy and 0.005% Stock Exchange trading fee) without interest.

Determination of Offer Price and Allocation of Hong Kong Offer Shares

The Offer Price is expected to be fixed on or around Thursday, December 5, 2019. Applicants are required to pay the maximum Offer Price of trading fee) without interest. HK$10.20 for each Offer Share together with 1.0% brokerage, 0.0027% SFC transaction levy and 0.005% Stock Exchange trading fee. If the Offer Price is not agreed between the Company and the Joint Global Offer Shares” section of the Prospectus. Coordinators (for themselves and on behalf of the Underwriters) on or before Monday, December 9, 2019, the Global Offering will not proceed. Applications for Hong Kong Offer Shares will not be processed and of persons who have given no allotment of any Hong Kong Offer Shares will be made until the application lists close. The allocation of the Offer Shares between the Hong Kong Public and provisions in the Prospectus shall prevail. Offering and the International Offering will be subject to reallocation as described in the section headed “Structure of the Global Offering” in the Prospectus. In accordance with Guidance Letter HKEX-GL91-18 issued HKSCC Nominees: by the Stock Exchange, if such reallocation is done in the circumstance • “Applicants’ declaration” on the first page; that the International Offering is undersubscribed or other than pursuant to the clawback mechanism as described in the section headed “Structure • “Warning” on the first page; of the Global Offering – The Hong Kong Public Offering – Reallocation”, • “If you are a nominee”; the total number of Offer Shares available under the Hong Kong Public • Offering following such reallocation shall be not more than 35,884,000 Offer Shares (representing approximately 20% of the total number of Offer Shares initially available under the Global Offering). The Company expects to announce the final Offer Price, the indication of registered as the holder of the Hong Kong Offer Shares; the level of interest in the International Offering, the level of applications • under the Hong Kong Public Offering and the basis of allocation of the whole or in part)”; and Hong Kong Offer Shares on Wednesday, December 11, 2019 in South • “Refund of your money”. China Morning Post (in English), the Hong Kong Economic Times (in Chinese), the website of the Stock Exchange at www.hkexnews.hk and the Company’s website at www.alphamabonc.com . Results of allocations in Hong Kong Public Offering, and the Hong Kong Identity signed by HKSCC Nominees: Card/passport/Hong Kong business registration numbers of successful • “8. How many applications can you make”; and applicants (where applicable) will be available on the above websites.

The refund procedures are stated in the “14. Despatch/Collection of Share Certificates and Refund Monies” in the “How to Apply for Hong Kong Offer Shares” section of the Prospectus.

Application by HKSCC Nominees Limited (“HKSCC Nominees”)

Where this Application Form is signed by HKSCC Nominees on behalf Applications for Hong Kong Offer Shares will not be processed and of persons who have given electronic application instructions to apply no allotment of any Hong Kong Offer Shares will be made until the for the Hong Kong Offer Shares, the provisions of this Application Form application lists close. which are inconsistent with those set out in the Prospectus shall not apply The allocation of the Offer Shares between the Hong Kong Public and provisions in the Prospectus shall prevail. Offering and the International Offering will be subject to reallocation as Without limiting the generality of this paragraph, the following sections described in the section headed “Structure of the Global Offering” in the of this Application Form are inapplicable where this form is signed by Prospectus. In accordance with Guidance Letter HKEX-GL91-18 issued HKSCC Nominees: by the Stock Exchange, if such reallocation is done in the circumstance • “Applicants’ declaration” on the first page; that the International Offering is undersubscribed or other than pursuant to the clawback mechanism as described in the section headed “Structure • “Warning” on the first page; of the Global Offering – The Hong Kong Public Offering – Reallocation”, • “If you are a nominee”; the total number of Offer Shares available under the Hong Kong Public • All representations and warranties under the “Effect of completing Offering following such reallocation shall be not more than 35,884,000 and submitting this Application Form” section, except the first one Offer Shares (representing approximately 20% of the total number of regarding registration of Hong Kong Offer Shares in the applicant’s Offer Shares initially available under the Global Offering). name and the signing of documents to enable the applicant to be The Company expects to announce the final Offer Price, the indication of registered as the holder of the Hong Kong Offer Shares;

• “If your application for Hong Kong Offer Shares is successful (in whole or in part)”; and

The following sub-sections in the “How to Apply for Hong Kong Offer Shares” section of the Prospectus are inapplicable where this form is signed by HKSCC Nominees:

• “12. Circumstances in which you will not be allotted Offer Shares”.

• Effect of the Information You Give to Computershare Hong Kong Investor Services Limited

If your application for Hong Kong Offer Shares is successful (in whole or in part)

If you apply for 1,000,000 or more Hong Kong Offer Shares, you may collect your share certificate(s) and/or refund cheque(s) in person from: Computershare Hong Kong Investor Services Limited at Shops 17121716, 17th Floor, Hopewell Centre, 183 Queen’s Road East, Wanchai, Hong Kong from 9:00 a.m. to 1:00 p.m. on Wednesday, December 11, 2019 or such other date as notified by us in the newspapers.

Computershare Hong Kong Investor Services Limited and its related bodies’ corporate, directors, officers, employees and agents (“ Representatives ”) expressly disclaim and exclude to the maximum extent permitted by law any liability for any loss or damage suffered or incurred by the applicant or any other person or entity however caused relating in any way to, or connected with, any information provided by or on behalf of the applicant on or in connection with this document or any services provided hereunder, or any other written or oral communication provided by or on behalf of the applicant in connection with this document or any services provided hereunder. This includes, without limitation, any errors or omissions in such information however caused, or the Representatives or any other person or entity placing any reliance on such information or any documentation, image, recording or reproduction of such information, or its accuracy, completeness, currency or reliability.

If you are an individual who is eligible for personal collection, you must not authorise any other person to collect for you. If you are a corporate applicant which is eligible for personal collection, your authorised representative must bear a letter of authorisation from your corporation stamped with your corporation’s chop. Both individuals and authorised representatives must produce, at the time of collection, evidence of identity acceptable to Computershare Hong Kong Investor Services Limited.

如 閣下欲以本身名義登記將獲發行的香港發售股份，請使用本表格

==> picture [172 x 41] intentionally omitted <==

ALPHAMAB ONCOLOGY 康寧傑瑞生物製藥

（於開曼群島註冊成立的有限公司）

全球發售

• 確認 閣下知悉招股章程內有關全球發售的限制；

• • 同意本公司、聯席保薦人、聯席全球協調人、聯席賬簿 管理人、聯席牽頭經辦人、包銷商、其各自的董事、高 級人員、僱員、合夥人、代理、顧問及參與全球發售的 任何其他各方現時及日後均毋須對並非載於招股章程

• （及其任何補充文件）的任何資料及陳述負責；

申請條件

• 甲. 可提出申請的人士

• 閣下及 閣下為其利益提出申請的任何人士必須年滿18 歲並有香港地址。

• 如 閣下為商號，申請必須以個別成員名義提出。 3. 聯名申請人不得超過四名。 （及其任何補充文件）的任何資料及陳述負責； 4. 如 閣下為法人團體，申請須經獲正式授權人員簽署， • 承諾及確認 閣下或 閣下為其利益提出申請的人士並 無申請或接納或表示有意認購（亦不會申請或接納或表

並註明其所屬代表身份及蓋上公司印章。 示有意認購）國際發售中的任何國際發售股份，亦無參

1. 閣下必須身處美國境外，並非美籍人士（定義見美國 與國際發售；

《證券法》S規例）或美國《證券法》S規例第902條第(h) • 同意應本公司、香港股份過戶登記處、收款銀行、聯席

(3)段所述人士，亦非中國法人或自然人。 保薦人、聯席全球協調人、聯席賬簿管理人、聯席牽頭

1. 除非為《上市規則》及聯交所發出的指引信所容許，或 經辦人、包銷商及╱或其各自的顧問及代理的要求，

聯交所已授出任何相關豁免，否則下列人士不得申請認 向其披露所要求提供有關 閣下及 閣下為其利益提出

購任何香港發售股份： 申請的人士的任何個人資料；

• 本公司及╱或其任何附屬公司股份的現有實益擁 • 若香港境外任何地方的法例適用於 閣下的申請，則同

有人； 意及保證 閣下已遵守所有有關法例，且本公司、聯席

• 本公司及╱或其任何附屬公司的董事或首席執行 保薦人、聯席全球協調人、聯席賬簿管理人、聯席牽頭

官； 經辦人及包銷商及其各自的高級人員或顧問概不會因接

• 上述任何人士的緊密聯繫人（定義見《上市規 納 閣下的購買要約，或 閣下在招股章程及本申請表

則》）； 格所載的條款及條件項下的權利及責任所引致的任何行

• 本公司核心關連人士（定義見《上市規則》）或緊隨 動，而違反香港境外的任何法例；

全球發售完成後將成為本公司核心關連人士的人 • 同意 閣下的申請一經接納，即不得因無意的失實陳述 士；或 而撤銷；

• 已獲分配或已申請或表示有意申請任何國際發售股 • 同意 閣下的申請受香港法例規管； 份或以其他方式參與國際發售的人士。 • 聲明、保證及承諾：(i) 閣下明白香港發售股份不曾亦

乙. 如 閣下為代名人 不會根據美國《證券法》登記； 及(ii) 閣下及 閣下為 閣下作為代名人可提交超過一份香港發售股份申請，方法 其利益申請香港發售股份的任何人士均身處美國境外 是：(i)透過中央結算及交收系統（「 中央結算系統 」）向香港 （定義見S規例），或屬S規例第902條第(h)(3)段所述人 結算發出 電子認購指示 （如 閣下為中央結算系統參與者）； 士； 或(ii)使用 白色 或 黃色 申請表格，以本身名義代表不同的實益 • 保證 閣下提供的資料真實及準確； 擁有人提交超過一份申請。 • 同意接納所申請的香港發售股份或根據申請向 閣下所 丙. 填寫及遞交本申請表格的效用 分配任何較少數目的股份； 閣下填妥並遞交本申請表格，即表示 閣下（如屬聯名申請 • 授權本公司將 閣下的姓名╱名稱列入本公司股東名 冊，作為 閣下獲分配的任何香港發售股份的持有人，

人，即各人共同及個別）代表 閣下本身，或作為 閣下代

• 授權本公司將 閣下的姓名╱名稱列入本公司股東名 冊，作為 閣下獲分配的任何香港發售股份的持有人， 並授權本公司及╱或其代理以普通郵遞方式按本申請 所示地址向 閣下或聯名申請的排名首位申請人寄發 任何股票及╱或任何退款支票，郵誤風險由 閣下承 擔，除非 閣下合資格親身領取股票及╱或退款支票；

• 其行事的每位人士的代理或代名人：

• 承諾簽立所有相關文件，並指示及授權本公司及╱或 作為本公司代理的聯席全球協調人（或其代理或代名 人），為按照組織章程細則的規定將 閣下獲分配的任 何香港發售股份以 閣下名義登記而代表 閣下簽立任 何文件及代 閣下進行一切必需事宜；

• 聲明及陳述此乃 閣下為本身或 閣下為其利益提出申 請的人士提出及擬提出的唯一申請；

• 明白本公司及聯席全球協調人將依賴 閣下的聲明及陳 述以決定是否向 閣下配發任何香港發售股份， 閣下 如作出虛假聲明，可能會被檢控；

• 同意遵守《公司條例》、《公司（清盤及雜項條文）條例》 及組織章程細則；

• 確認 閣下已閱讀招股章程及本申請表格所載條款及條 件以及申請程序，並同意受其約束；

• （倘本申請為 閣下本身的利益提出）保證 閣下或作 為 閣下代理的任何人士或任何其他人士不曾亦不會 為 閣下利益而以 白色 或 黃色 申請表格或向香港結算或 透過 白表eIPO 服務供應商發出 電子認購指示 而提出其 他申請；及

• 確認 閣下已收到及閱讀招股章程，且 閣下提出申請 時僅依賴招股章程所載資料及陳述而不會依賴任何其他 資料或陳述（招股章程任何補充文件所載者除外）；

如 閣下欲以本身名義登記將獲發行的香港發售股份，請使用本表格

如 閣下並未在指定領取期間內親身領取退款支票及╱或股 票，有關退款支票及╱或股票將即時以普通郵遞方式寄往本 申請表格所示地址，郵誤風險由 閣下承擔。 如 閣下申請認購1,000,000股以下香港發售股份， 閣下的 退款支票及╱或股票將於2019年12月11日（星期三）或之 前以普通郵遞方式寄往有關申請表格所示地址，郵誤風險 由 閣下承擔。

• （倘 閣下作為代理為另一人士的利益提出申請）保證 (i) 閣下（作為代理或為該人士利益）或該人士或任何 其他作為該人士代理的人士不曾亦不會以 白色 或 黃色 申 請表格或向香港結算發出 電子認購指示 而提出其他申 請；及(ii) 閣下獲正式授權作為該其他人士的代理代 。

• 為簽署申請表格或發出 電子認購指示

• 丁. 授權書

退回款項

• 如 閣下透過授權人士提出申請，本公司及聯席全球協調人 可按其認為合適的條件（包括出示獲授權證明）酌情接納或 拒絕 閣下的申請。

若 閣下未獲分配任何香港發售股份或申請僅部分獲接納， 可按其認為合適的條件（包括出示獲授權證明）酌情接納或 本公司將不計利息退回 閣下的申請股款（包括相關的1.0% 拒絕 閣下的申請。 經紀佣金、0.0027%證監會交易徵費及0.005%聯交所交易 釐定發售價及分配香港發售股份 費）。如發售價低於最高發售價，本公司將不計利息向 閣 預期發售價將於2019年12月5日（星期四）或前後釐定。申請 下退回多收申請股款（包括相關的1.0%經紀佣金、0.0027% 人須繳付每股發售股份最高發售價10.20港元，另加1.0%經 證監會交易徵費及0.005%聯交所交易費）。 紀佣金、0.0027%證監會交易徵費及0.005%聯交所交易費。 有關退款程序載於招股章程「如何申請香港發售股份」一節 倘若本公司與聯席全球協調人（為其本身及代表包銷商）並 「14. 發送╱領取股票及退回股款」。 無於2019年12月9日（星期一）或之前協定發售價，全球發售 香港中央結算（代理人）有限公司（「香港結算代理人」）提出 將不會進行。 的申請 截止辦理申請登記前概不處理香港發售股份的申請或配發任 如本申請表格由香港結算代理人代表發出 電子認購指示 申請 何香港發售股份。 香港發售股份的人士簽署，本申請表格與招股章程所載不一 香港公開發售與國際發售之間的發售股份分配將按招股章 致的條文將不適用而以招股章程所述者為準。 程「全球發售的架構」一節所述予以重新分配。根據聯交所 在不限制此段一般性的原則下，本申請表格的以下部分在香 發出的指引信HKEX-GL91-18，倘上述重新分配在國際發售 港結算代理人作簽署人的情況下並不適用： 認購不足的情況下或並非根據「全球發售的架構－香港公開 • 第一頁的「申請人聲明」； 發售－重新分配」一節所載回補機制作出，則有關重新分 • 第一頁的「警告」； 配後香港公開發售項下可供認購的發售股份總數不得超過 • 「如 閣下為代名人」； 35,884,000股發售股份（佔全球發售項下初步可供認購發售股 • 「填寫及遞交本申請表格的效用」一節下的所有陳述及 份總數的約20%）。 保證，惟首項有關以申請人名義登記香港發售股份及簽 本公司預期於2019年12月11日（星期三）在《南華早報》（以英 署使申請人登記成為香港發售股份持有人的文件除外； 文）、《香港經濟日報》（以中文）、聯交所網站 www.hkexnews.hk • 「如 閣下成功申請認購香港發售股份（全部或部 及本公司網站 www.alphamabonc.com 公佈最終發售價、國際發 分）」；及 售踴躍程度、香港公開發售申請水平及香港發售股份分配基 • 「退回款項」。 準。香港公開發售的分配結果及獲接納申請人的香港身份 招股章程「如何申請香港發售股份」一節的以下分節在香港 證╱護照╱香港商業登記號碼（如適用）亦將於上述網站公 結算代理人作簽署人的情況下並不適用： 佈。 • 「8. 閣下可提交的申請數目」；及 如 閣下成功申請認購香港發售股份（全部或部分） • 「12. 閣下不獲配發發售股份的情況」。 如 閣下申請認購1,000,000股或以上香港發售股份， 閣下 閣下提供給香港中央證券登記有限公司的資料的有關影響 可於2019年12月11日（星期三）上午九時正至下午一時正或 香港中央證券登記有限公司及其關聯法人團體、董事、高級 我們於報章通知的其他日期，親臨香港中央證券登記有限 人員、僱員及代理人（「 代表 」）在法律所容許的最大限度內 公司（地址為香港灣仔皇后大道東183號合和中心17樓1712明確卸棄及免除在任何方面與申請人或代表申請人於本文件 1716號舖）領取股票及╱或退款支票。 所提供或與本文件或在本文件下提供的任何服務相關的任何

香港中央證券登記有限公司及其關聯法人團體、董事、高級 人員、僱員及代理人（「 代表 」）在法律所容許的最大限度內 明確卸棄及免除在任何方面與申請人或代表申請人於本文件 所提供或與本文件或在本文件下提供的任何服務相關的任何 資料，或任何申請人或代表申請人提供與本文件或在本文件 下提供的任何服務相關的任何其他書面或口頭通訊，有關或 相關由申請人或任何其他人士或實體所遭受或招致不論如何 造成的任何損失或損害的任何法律責任。此包括但不限於該 等資料中不論如何造成的任何錯誤或遺漏，或代表或任何其 他人士或實體對該等資料或任何該等資料的文件記錄、影 像、記錄或複製品作出的任何依據，或其準確性、完整性、 合時性或可靠性。

• 如 閣下為個人申請人並合資格親身領取， 閣下不得授權 任何其他人士代為領取。如 閣下為公司申請人並合資格派 人領取， 閣下的授權代表須攜同蓋上公司印章的公司授權 書方可領取。個人及授權代表均須於領取時出示香港中央證 券登記有限公司接納的身份證明文件。

Please use this form if you want the Hong Kong Offer Shares to be issued in your name

Personal Data

Personal Information Collection Statement

• any other incidental or associated purposes relating to the above and/or to enable the Company and the Hong Kong Share Registrar to discharge their obligations to holders of securities and/or regulators and/or any other purpose to which the holders of securities may from time to time agree.

This Personal Information Collection Statement informs the applicant for, and holder of, Hong Kong Offer Shares, of the policies and practices of the Company and its Hong Kong Share Registrar in relation to personal data and the Personal Data (Privacy) Ordinance (Chapter 486 of the Laws of Hong Kong) (the “ Ordinance ”).

3. Transfer of personal data Personal data held by the Company and its Hong Kong Share Registrar relating to the securities holders will be kept confidential but the Company and its Hong Kong Share Registrar may, to the extent necessary for achieving any of the above purposes, disclose, obtain or transfer (whether within or outside Hong Kong) the personal data to from or with any of the following:

1. Reasons for the collection of your personal data It is necessary for applicants and registered holders of securities to supply correct personal data to the Company or its agents and the Hong Kong Share Registrar when applying for securities or transferring securities into or out of their names or in procuring the services of the Hong Kong Share Registrar.

• the Company’s appointed agents such as financial advisers, receiving banker and overseas principal share registrar;

Failure to supply the requested data may result in your advisers, receiving banker and overseas principal application for securities being rejected, or in delay or share registrar; the inability of the Company or its Hong Kong Share • where applicants for securities request a deposit Registrar to effect transfers or otherwise render their into CCASS, HKSCC or HKSCC Nominees, who services. It may also prevent or delay registration or will use the personal data for the purposes of transfers of the Hong Kong Offer Shares which you operating CCASS; have successfully applied for and/or the dispatch of • any agents, contractors or third-party service providers share certificate(s) and/or refund cheque(s) to which who offer administrative, telecommunications, you are entitled. computer, payment or other services to the Company or the Hong Kong Share Registrar It is important that securities holders inform the Company in connection with their respective business and the Hong Kong Share Registrar immediately of any operation; inaccuracies in the personal data supplied. • the Stock Exchange, the SFC and any other statutory regulatory or governmental bodies or otherwise as 2. Purposes required by laws, rules or regulations; and The personal data of the securities holders may be used, • any persons or institutions with which the securities’ held, processed, and/or stored (by whatever means) for holders have or propose to have dealings, such as the following purposes: their bankers, solicitors, accountants or stockbrokers • processing of your application and e-Refund etc. payment instructions/refund cheque, where applicable, and verification of compliance with the 4. Retention of personal data terms and application procedures set out in this The Company and its Hong Kong Share Registrar will form and the Prospectus and announcing results of keep the personal data of the applicants and holders of allocation of the Hong Kong Offer Shares; securities for as long as necessary to fulfil the purposes • enabling compliance with all applicable laws and for which the personal data were collected. Personal data regulations in Hong Kong and elsewhere; which is no longer required will be destroyed or dealt with • registering new issues or transfers into or out of in accordance with the Ordinance. the names of holders of securities including, where 5. Access to and correction of personal data applicable, in the name of HKSCC Nominees; Securities holders have the right to ascertain whether the • maintaining or updating the registers of holders of Company or the Hong Kong Share Registrar hold their securities of the Company; personal data, to obtain a copy of that data, and to correct • conducting or assisting to conduct signature any data that is inaccurate. The Company and the Hong verifications, any other verification or exchange of Kong Share Registrar have the right to charge a reasonable information; fee for the processing of such requests.

• establishing benefit entitlements of holders of securities of the Company, such as dividends, rights issues and bonus issues, etc;

All requests for access to data or correction of data should be addressed to us, at our registered address disclosed in the “Corporate Information” section of the Prospectus or as notified from time to time, for the attention of the company secretary, or our Hong Kong Share Registrar for the attention of the privacy compliance officer.

• distributing communications from the Company and its subsidiaries;

• compiling statistical information and Shareholder profiles;

• making disclosures as required by laws, rules or regulations;

By signing an Application Form or by giving electronic application instructions to HKSCC, you agree to all of the above.

• disclosing identities of successful applicants by way of press announcement(s) or otherwise;

• disclosing relevant information to facilitate claims on entitlements; and

如 閣下欲以本身名義登記將獲發行的香港發售股份，請使用本表格

個人資料

• 與上述者有關的任何其他附帶或相關目的 及╱或使本公司及香港股份過戶登記處能 履行對證券持有人及╱或監管機構承擔的 責任及╱或證券持有人不時同意的任何其 他目的。

個人資料收集聲明

此項個人資料收集聲明是向香港發售股份的申請人 和持有人說明本公司及其香港股份過戶登記處有關 個人資料和香港法例第486章《個人資料（私隱）條 例》（「 《條例》 」）方面的政策和慣例。

3. 轉交個人資料

1. 收集 閣下個人資料的原因

  - 本公司及其香港股份過戶登記處所持有關證券 持有人的個人資料將會保密，但本公司及其香 港股份過戶登記處可以在為達到上述任何目的 之必要情況下，向下列任何人士披露、獲取或 轉交（無論在香港境內或境外）有關個人資料：

• 證券申請人及登記持有人以本身名義申請證券 持有人的個人資料將會保密，但本公司及其香

• 或轉讓或受讓證券時或尋求香港股份過戶登記 港股份過戶登記處可以在為達到上述任何目的 處的服務時，必須向本公司或其代理及香港股 之必要情況下，向下列任何人士披露、獲取或 份過戶登記處提供準確個人資料。 轉交（無論在香港境內或境外）有關個人資料： • 本公司委任的代理，如財務顧問、收款銀 行及海外主要股份過戶登記處；

• 未能提供所要求的資料可能導致 閣下的證券 • （如證券申請人要求將證券存於中央結算

• 申請被拒或延遲，或本公司或其香港股份過戶 系統）香港結算或香港結算代理人；其將

• 登記處無法落實轉讓或提供服務。此舉亦可能 會就中央結算系統的運作使用有關個人資

• 妨礙或延遲登記或轉讓 閣下成功申請的香港 料；

• 發售股份及╱或寄發 閣下應得的股票及╱或 • 向本公司或香港股份過戶登記處提供與其

• 退款支票。 各自業務運作有關的行政、電訊、電腦、 付款或其他服務的任何代理、承包商或第

• 證券持有人所提供的個人資料如有任何錯誤， 三方服務供應商； 須立即通知本公司及香港股份過戶登記處。 • 聯交所、證監會及任何其他法定監管機關 或政府部門或遵照其他法例、規則或規 例；及

• 2. 目的 • 證券持有人與其進行或擬進行交易的任何

• 證券持有人的個人資料可以任何方式被採用、 人士或機構，如其銀行、律師、會計師或

• 持有、處理及╱或保存，以作下列用途： 股票經紀等。

• • 處理 閣下的申請及電子退款指示╱退款 支票（如適用）、核實是否符合本表格及招 4. 保留個人資料

• 股章程所載條款及申請程序及公佈香港發 本公司及其香港股份過戶登記處將按收集個人

• 售股份的分配結果； 資料所需的用途保留證券申請人及持有人的個

• • 遵守香港及其他地區的所有適用法律法 人資料。無需保留的個人資料將會根據《條例》 規； 銷毀或處理。

• • 以證券持有人（包括香港結算代理人（如適 5. 查閱和更正個人資料

• 用））的名義登記新發行證券或轉讓或受讓 證券持有人有權確定本公司或香港股份過戶登

• 證券；

  • 證券持有人有權確定本公司或香港股份過戶登 記處是否持有其個人資料，並有權索取有關該 資料的副本並更正任何不準確資料。本公司及 香港股份過戶登記處有權就處理任何查閱資料 的要求收取合理費用。

• 存置或更新本公司證券持有人的名冊；

• 進行或協助進行簽名核對、任何其他核對 或交換資料；

• 確定本公司證券持有人的受益權利，如股 息、供股及紅股等；

所有查閱資料或更正資料的要求應按招股章程 「公司資料」一節所披露或不時通知的本公司註 冊地址送交公司秘書，或向我們的香港股份過 戶登記處的私隱事務主任提出。

• 分發本公司及其附屬公司的通訊；

• 編製統計資料及股東資料；

• 遵照法律、規則或法規的要求作出披露；

• 透過報章公告或其他方式披露獲接納申請 人的身份；

閣下簽署申請表格或向香港結算發出電子認購指 示，即表示同意上述各項。

• 披露有關資料以便就權益提出申索；及